Form 4: Alphatec General Counsel Sells $491K in Stock
Insider Stock Sale
Alphatec Holdings' General Counsel, Tyson Eliot Marshall, sold 22,889 shares of common stock for approximately $491,550, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Tyson Eliot Marshall, General Counsel & Corporate Secretary of Alphatec Holdings, Inc. (ATEC), reported the sale of 22,889 shares of common stock.
- The sales occurred on December 5, 2025.
- The first transaction involved 9,924 shares sold at a weighted average price of $21.48 per share, with prices ranging from $21.33 to $21.63.
- The second transaction involved 12,965 shares sold at a weighted average price of $21.47 per share, with prices ranging from $21.32 to $21.65.
- Total estimated proceeds from these sales amount to approximately $491,550.
- Following these transactions, Marshall beneficially owns 345,442 shares of Alphatec Holdings common stock.
- The sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025.
Sentiment
Score: 4
Explanation: While the sale was pre-planned under a 10b5-1 plan, insider selling, especially by a key executive, can still be viewed with some caution by investors. The pre-planned nature mitigates the negative sentiment compared to an unplanned sale, but it's not a positive signal.
Negatives
- An insider, the General Counsel, sold a significant number of shares (22,889 shares), which could be interpreted negatively by some investors, despite being pre-planned.
- The total value of shares sold was approximately $491,550.
Risks
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence in the company's future prospects, potentially leading to negative investor sentiment.
Future Outlook
NA
Industry Context
This Form 4 filing reports an insider stock sale, which is a routine disclosure for publicly traded companies. It does not provide specific industry context or trends, but Alphatec Holdings operates in the medical device sector, specifically spine surgery.
Related Party Transactions
- The reported sales of common stock by the General Counsel constitute a related party transaction.
Stakeholder Impact
- Shareholders: May interpret the insider sale as a neutral event due to the 10b5-1 plan, or as a slight negative signal regarding future growth prospects, potentially influencing short-term sentiment.
Key Dates
| Date | Description |
|---|---|
| 2025-03-14 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 2025-12-05 | Date of the reported stock transactions (sales). |
| 2025-12-09 | Date the Form 4 was signed by the reporting person. |
Recommendation
holdThe insider sale, while significant in value, was conducted under a pre-arranged 10b5-1 trading plan. This suggests the sale was for personal financial planning rather than a reaction to new, adverse company information. Without additional context from other filings (e.g., earnings reports, strategic updates), this Form 4 alone does not provide sufficient grounds for a 'buy' or 'sell' recommendation, thus a 'hold' is appropriate as it's a neutral event in isolation.
Keywords
Alphatec Holdings, ATEC, Insider Trading, Form 4, Stock Sale, Tyson Eliot Marshall, General Counsel, 10b5-1 Plan, SEC Filing, Medical Devices, Spine Surgery
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.